Cytokinetics (NASDAQ:CYTK) Shares Gap Down Following Insider Selling
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report)’s stock price gapped down before the market opened on Monday following insider selling activity. The stock had previously closed at $51.86, but opened at $50.79. Cytokinetics shares last traded at $50.69, with a volume of 143,664 shares. Specifically, CEO Robert I. Blum sold 5,000 shares of the company’s […]
More Stories
Pfizer Inc. (NYSE:PFE) Holdings Raised by Elevation Point Wealth Partners LLC
Elevation Point Wealth Partners LLC increased its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 15.9% in the 1st...
Dynamic Advisor Solutions LLC Cuts Holdings in Pfizer Inc. (NYSE:PFE)
Dynamic Advisor Solutions LLC lessened its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 9.6% in the first quarter,...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...